Elanco Animal Health (ELAN) Total Current Liabilities (2017 - 2026)
Elanco Animal Health (ELAN) posted Total Current Liabilities of $1.7 billion for Q1 2026, up 4.07% sequentially from $1.6 billion in Q4 2025, and up 30.97% YoY from $1.3 billion in Q1 2025.
Elanco Animal Health (ELAN) Total Current Liabilities (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Total Current Liabilities for 10 years, with the latest figure at $1.7 billion in Q1 2026.
- Quarterly Total Current Liabilities rose 30.97% year-over-year to $1.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 billion (up 30.97% YoY) and the FY2025 annual result came in at $1.6 billion, up 21.44% from the prior year.
- Total Current Liabilities grew to $1.7 billion in Q1 2026 per ELAN's latest filing, from $1.6 billion in the prior quarter.
- Over five years, Total Current Liabilities peaked at $1.7 billion in Q4 2022 and troughed at $1.2 billion in Q1 2024.
- A 5-year average of $1.4 billion and a median of $1.3 billion in 2022 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2026: Total Current Liabilities plunged 35.74% in 2022, then soared 30.97% in 2026.
- Over 5 years, Total Current Liabilities stood at $1.7 billion in 2022, then slipped by 27.09% to $1.2 billion in 2023, then climbed by 5.96% to $1.3 billion in 2024, then rose by 21.44% to $1.6 billion in 2025, then climbed by 4.07% to $1.7 billion in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $1.7 billion, $1.6 billion, and $1.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 1.79 Bn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 662.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.85 Bn |
| Mar 31, 2026 | 1.66 Bn |
| Dec 31, 2025 | 1.60 Bn |
| Sep 30, 2025 | 1.46 Bn |
| Jun 30, 2025 | 1.39 Bn |
| Mar 31, 2025 | 1.27 Bn |
| Dec 31, 2024 | 1.32 Bn |
| Sep 30, 2024 | 1.32 Bn |
| Jun 30, 2024 | 1.37 Bn |
| Mar 31, 2024 | 1.23 Bn |
| Dec 31, 2023 | 1.24 Bn |
| Sep 30, 2023 | 1.27 Bn |
| Jun 30, 2023 | 1.28 Bn |
| Mar 31, 2023 | 1.58 Bn |
| Dec 31, 2022 | 1.70 Bn |
| Sep 30, 2022 | 1.61 Bn |
| Jun 30, 2022 | 1.34 Bn |
| Mar 31, 2022 | 1.31 Bn |
| Dec 31, 2021 | 1.65 Bn |
| Sep 30, 2021 | 1.36 Bn |